Peter Gueldner

Title: Peter Gueldner: Innovator in Oral Dosage Forms

Introduction

Peter Gueldner is a notable inventor based in Germany, recognized for his contributions to the field of pharmaceutical formulations. He has developed innovative oral dosage forms that enhance the delivery of active ingredients in medications.

Latest Patents

Peter Gueldner holds a patent for an oral dosage form for propiverine or its pharmaceutically acceptable salts, which focuses on the extended release of the active ingredient. This patent describes the production of oral pharmaceutical compositions containing propiverine in amounts ranging from 4 mg to 60 mg, designed for prolonged release. The formulation preferably includes a blend of the active agent and one or more acidic substances with a pKa value of less than 6.65, which are either coated with a retarding layer or embedded in a matrix.

Career Highlights

Peter Gueldner is associated with Apogepha Arzneimittel GmbH, where he has made significant strides in pharmaceutical innovation. His work emphasizes the importance of effective drug delivery systems, particularly in the treatment of conditions requiring propiverine.

Collaborations

Peter has collaborated with notable colleagues such as Thomas Gramatte and Peter Gruber, contributing to advancements in pharmaceutical research and development.

Conclusion

Peter Gueldner's work in the field of oral dosage forms exemplifies the importance of innovation in pharmaceuticals. His contributions continue to influence the development of effective medication delivery systems.